Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 15/20 | 0.68 |
| ▸ | CNR1 | P21554 | 11/20 | 0.68 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1620771 | 0.90 | CNR1 (0.51) | CNR2CNR1NPY5RGAA | |
| SCHEMBL1621406 | 0.85 | CNR2 (0.58) | CNR2CNR1EGFRHPGDMAPK14 | |
| SCHEMBL1464269 | 0.81 | CNR2 (1.00) | CNR2CNR1CYP2C8CYP2D6CYP2C19 | |
| SCHEMBL4013229 | 0.81 | CNR2 (0.56) | CNR2CNR1CYP2C8CYP2D6CYP2C19 | |
| SCHEMBL2254622 | 0.79 | CNR2 (0.66) | CNR2CNR1CYP2C8CYP2D6CYP2C19 | |
| SCHEMBL4011949 | 0.79 | CNR2 (0.55) | CNR2CNR1CYP2C8CYP2D6CYP2C19 | |
| SCHEMBL3658651 | 0.78 | CNR2 (0.58) | CNR2CNR1CYP2C8CYP2D6CYP2C19 | |
| SCHEMBL3968895 | 0.77 | CNR2 (0.67) | CNR2CNR1NPY5R | |
| SCHEMBL1463732 | 0.76 | CNR2 (1.00) | CNR2CNR1CYP2C8CYP2D6CYP2C19 | |
| SCHEMBL1621448 | 0.76 | CNR1 (0.49) | CNR2CNR1NPY5RGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2074084-A1 | COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | Boehringer Ingelheim International GmbH (DE) | 2009-07-01 | — | — | EP | disclosed |
| WO-2008039645-A1 | COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-04-03 | — | — | WO | disclosed |